ATE546196T1 - Verwendung und substanzen zur wahrnehmung oder kontrolle von alkoholeinnahme - Google Patents

Verwendung und substanzen zur wahrnehmung oder kontrolle von alkoholeinnahme

Info

Publication number
ATE546196T1
ATE546196T1 AT05793300T AT05793300T ATE546196T1 AT E546196 T1 ATE546196 T1 AT E546196T1 AT 05793300 T AT05793300 T AT 05793300T AT 05793300 T AT05793300 T AT 05793300T AT E546196 T1 ATE546196 T1 AT E546196T1
Authority
AT
Austria
Prior art keywords
alcohol
membrane
perception
substances
control
Prior art date
Application number
AT05793300T
Other languages
English (en)
Inventor
Jean-Noel Colombani
Original Assignee
Jnc Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jnc Innovations filed Critical Jnc Innovations
Application granted granted Critical
Publication of ATE546196T1 publication Critical patent/ATE546196T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05793300T 2004-07-23 2005-07-22 Verwendung und substanzen zur wahrnehmung oder kontrolle von alkoholeinnahme ATE546196T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408155A FR2873292B1 (fr) 2004-07-23 2004-07-23 Composes et methodes pour controler la prise d'alcool
PCT/FR2005/001903 WO2006018521A2 (fr) 2004-07-23 2005-07-22 Composes et methodes pour controler la prise d'alcool.

Publications (1)

Publication Number Publication Date
ATE546196T1 true ATE546196T1 (de) 2012-03-15

Family

ID=34949587

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05793300T ATE546196T1 (de) 2004-07-23 2005-07-22 Verwendung und substanzen zur wahrnehmung oder kontrolle von alkoholeinnahme

Country Status (4)

Country Link
EP (2) EP1786405B1 (de)
AT (1) ATE546196T1 (de)
FR (1) FR2873292B1 (de)
WO (1) WO2006018521A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2906464B1 (fr) * 2006-09-29 2011-07-29 Europ Finances Composition active pour prevenir l'accoutumance a l'absorption des boissons alcoolisees

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
FR2642305A1 (fr) * 1989-01-27 1990-08-03 Theramex Laboratoire Nouvelles compositions de dermo-cosmetologie et leur procede d'obtention
FR2663945B1 (fr) * 1990-06-28 1994-09-09 Crueghe Henri Liquide inhibiteur de combustion auto extinguible.
FR2735658B1 (fr) * 1995-06-21 1997-09-12 Capsulis Encapsulation de composes a usage alimentaire par des tensioactifs
WO1993024106A1 (fr) * 1992-05-27 1993-12-09 L'oreal Composition comprenant un oligomere proanthocyanidinique encapsule dans un liposome
US6468554B1 (en) * 1994-06-07 2002-10-22 Ted Ichino Sensorially active substance embedded in plastic
KR100483391B1 (ko) * 1998-01-16 2005-04-15 칼라 액세스, 인크. 안정화된 미백 조성물 및 이의 제조 방법
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu

Also Published As

Publication number Publication date
FR2873292B1 (fr) 2008-05-30
FR2873292A1 (fr) 2006-01-27
WO2006018521A2 (fr) 2006-02-23
EP1786405B1 (de) 2012-02-22
EP1786405A2 (de) 2007-05-23
EP2258354A1 (de) 2010-12-08
EP2258354B1 (de) 2013-05-08
WO2006018521A3 (fr) 2006-04-13

Similar Documents

Publication Publication Date Title
WO2007143098A8 (en) Hepatocyte growth factor (hgf) binding proteins
WO2007143090A3 (en) Hepatocyte growth factor (hgf) binding proteins
DE602005020639D1 (de) Zusammensetzung aus milchsäure und lactoferrin
BRPI0616982B8 (pt) uso de oligouronato, composição farmacêutica inalável e aplicador de spray
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
WO2006067122A3 (en) Binding molecules capable of neutralizing west nile virus and uses thereof
DE502007001793D1 (de) Konditionierte blutzusammensetzung und verfahren zu deren herstellung
WO2007073911A3 (de) Geschmacksmaskierung von pulvern
EP2628749A3 (de) Antimikrobielle Kinocidinzusammensetzungen und Verwendungsverfahren
WO2006050729A3 (en) Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
WO2005107872A3 (en) Treating respiratory diseases with gycopyrrolate and analogues
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
DE502006002773D1 (de) Verwendung von Pelargonium Extrakten in Kombination mit Plantago zur Herstellung eines Medikaments zur Behandlung der Rachenentzündung
WO2009022347A3 (en) Device and method for treating respiratory and other diseases
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE488254T1 (de) Biologische wundversorgung und herstellungsverfahren dafür
WO2009023710A3 (en) Xanthohumol-enriched hop extract
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
WO2005089310A3 (en) Breath test for oral malodor
WO2005016947A3 (en) ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
BR0311700A (pt) Processo para a produção de uma preparação em forma de pelìcula e preparação em forma de pelìcula
WO2009019835A1 (ja) 生薬エキス配合液剤
ATE517877T1 (de) Neue arzneimittel zur behandlung von atemwegserkrankungen
WO2007109217A3 (en) Compounds from an extract of artemisia and methods for treating disorders
ATE546196T1 (de) Verwendung und substanzen zur wahrnehmung oder kontrolle von alkoholeinnahme